Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Arch Pharm (Weinheim) ; 345(12): 980-8, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23015381

RESUMO

A series of (E)-2-(4-cinnamylpiperazin-1-yl)-N-(1-substituted-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamides were synthesized and evaluated for their positive inotropic activity by measuring the left atrium stroke volume on isolated rabbit heart preparations. This class of compounds presented favorable in vitro activity compared with the standard drug, milrinone, among which N-(1-(3-chlorophenyl)-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)-2-(4-cinnamylpiperazin-1-yl)acetamide 5e was found to be the most potent with 16.58 ± 0.11% increased stroke volume (milrinone: 2.46 ± 0.07%) at a concentration of 3 × 10(-5) M. The chronotropic effects of the compounds having inotropic effects were also evaluated.


Assuntos
Acetamidas/síntese química , Função do Átrio Esquerdo/efeitos dos fármacos , Cardiotônicos/síntese química , Átrios do Coração/efeitos dos fármacos , Quinolinas/síntese química , Triazóis/síntese química , Acetamidas/química , Acetamidas/farmacologia , Animais , Cardiotônicos/química , Cardiotônicos/farmacologia , Técnicas In Vitro , Estrutura Molecular , Quinolinas/química , Quinolinas/farmacologia , Coelhos , Volume Sistólico/efeitos dos fármacos , Relação Estrutura-Atividade , Triazóis/química , Triazóis/farmacologia
2.
Bioorg Med Chem Lett ; 22(13): 4229-32, 2012 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-22672796

RESUMO

Two series of N-(1-oxo-1,2,4,5-tetrahydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamides bearing piperazine and 1,4-diazepane moieties were synthesized and screened for their positive inotropic activity by measuring left atrium stroke volume on isolated rabbit heart preparations. Most of the derivatives exhibited better in vitro positive inotropic activity than the existing drug, milrinone, among which 2-(4-(4-chlorobenzyl)-1,4-diazepan-1-yl)-N-(1-oxo-1,2,4,5-tetrahydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamide 6c proved to be the most potent with 15.48 ± 0.27% increased stroke volume (milrinone: 2.46 ± 0.07%) at a concentration of 3 × 10(-5) M. The chronotropic effects of the compounds that exhibited inotropic effects were also evaluated.


Assuntos
Acetamidas/química , Azepinas/química , Cardiotônicos/síntese química , Piperazinas/química , Quinolinas/síntese química , Triazóis/síntese química , Acetamidas/síntese química , Acetamidas/farmacologia , Animais , Cardiotônicos/química , Cardiotônicos/farmacologia , Átrios do Coração/efeitos dos fármacos , Piperazina , Quinolinas/química , Quinolinas/farmacologia , Coelhos , Volume Sistólico/efeitos dos fármacos , Triazóis/química , Triazóis/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA